Join the Omlyclo group to help and get support from people like you.
Omlyclo News
Monthly News Roundup - March 2025
FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (guselkumab) for the t...
American Academy of Allergy, Asthma & Immunology, Feb. 28-March 3
The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 3 in San Diego, drawing clinicians, academicians, allied health professionals, and others i...
FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair
JERSEY CITY, N.J., March 9, 2025 /PRNewswire/ – Celltrion today announced the U.S. Food and Drug Administration (FDA) approved Omlyclo® (omalizumab-igec) as the first and only biosimilar designated a...
Further information
Related condition support groups
Urticaria, Hives, Asthma - Maintenance, Chronic Rhinosinusitis with Nasal Polyps, Asthma, Nasal Polyps